Drug Profile
Ibuprofen - Techfields Pharma
Alternative Names: Ibuprofenamine - Techfields Pharma; X 0002Latest Information Update: 08 Mar 2024
Price :
$50
*
At a glance
- Originator Techfields Pharma
- Class Amines; Analgesics; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Fever; Osteoarthritis; Pain; Prostatitis; Spinal disorders
Most Recent Events
- 10 Jan 2024 Techfields Pharma completes a phase-III clinical trials in Pain in USA (Topical) (NCT03081806)
- 12 Jun 2023 Techfields Pharma withdraws a phase III trial in Osteoarthritis prior to enrolment due to strategic business decision (NCT03110523)
- 06 Feb 2023 Techfields Pharma completes a phase III trial in Osteoarthritis in China (In adults, In elderly) (Topical) (NCT05324163)